JPMorgan Chase & Co’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $49.6M | Buy |
|
|||||
|
2025
Q2 | $42M | Sell |
|
|||||
|
2025
Q1 | $114M | Buy |
|
|||||
|
2024
Q4 | $85.3M | Sell |
|
|||||
|
2024
Q3 | $95.1M | Buy |
|
|||||
|
2024
Q2 | $82M | Buy |
|
|||||
|
2024
Q1 | $96M | Buy |
|
|||||
|
2023
Q4 | $53.8M | Buy |
|
|||||
|
2023
Q3 | $39.5M | Buy |
|
|||||
|
2023
Q2 | $36.4M | Sell |
|
|||||
|
2023
Q1 | $36.4M | Buy |
|
|||||
|
2022
Q4 | $29.8M | Sell |
|
|||||
|
2022
Q3 | $27.5M | Sell |
|
|||||
|
2022
Q2 | $33.8M | Sell |
|
|||||
|
2022
Q1 | $72.5M | Buy |
|
|||||
|
2021
Q4 | $58.8M | Sell |
|
|||||
|
2021
Q3 | $95.3M | Buy |
|
|||||
|
2021
Q2 | $73.9M | Sell |
|
|||||
|
2021
Q1 | $71.9M | Buy |
|
|||||
|
2020
Q4 | $47.7M | Buy |
|
|||||
|
2020
Q3 | $32.4M | Buy |
|
|||||
|
2020
Q2 | $20.2M | Buy |
|
|||||
|
2020
Q1 | $12.3M | Buy |
|
|||||
|
2019
Q4 | $13M | Sell |
|
|||||
|
2019
Q3 | $17.6M | Buy |
|
|||||
|
2019
Q2 | $12M | Buy |
|
|||||
|
2019
Q1 | $12.5M | Buy |
|
|||||
|
2018
Q4 | $9.32M | Sell |
|
|||||
|
2018
Q3 | $17.1M | Buy |
|
|||||
|
2018
Q2 | $9.79M | Sell |
|
|||||
|
2018
Q1 | $11.9M | Sell |
|
|||||
|
2017
Q4 | $18.8M | Buy |
|
|||||
|
2017
Q3 | $18.1M | Sell |
|
|||||
|
2017
Q2 | $18.1M | Sell |
|
|||||
|
2017
Q1 | $24M | Sell |
|
|||||
|
2016
Q4 | $21.1M | Buy |
|
|||||
|
2016
Q3 | $22.7M | Buy |
|
|||||
|
2016
Q2 | $14.9M | Buy |
|
|||||
|
2016
Q1 | $11.9M | Buy |
|
|||||
|
2015
Q4 | $4.1M | Sell |
|
|||||
|
2015
Q3 | $3.39M | Sell |
|
|||||
|
2015
Q2 | $12.1M | Buy |
|
|||||
|
2015
Q1 | $9.71M | Buy |
|
|||||
|
2014
Q4 | $6.66M | Buy |
|
|||||
|
2014
Q3 | $5.82M | Sell |
|
|||||
|
2014
Q2 | $7.39M | Buy |
|
|||||
|
2014
Q1 | $7.42M | Sell |
|
|||||
|
2013
Q4 | $18.8M | Buy |
|
|||||
|
2013
Q3 | $4.87M | Buy |
|
|||||
|
2013
Q2 | $4.04M | Buy |
|